razoxane has been researched along with Extravasation of Contrast Media in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 22 (61.11) | 29.6817 |
| 2010's | 13 (36.11) | 24.3611 |
| 2020's | 1 (2.78) | 2.80 |
| Authors | Studies |
|---|---|
| Kazakova, V; Kozyreva, O; Torres, TA; Vanegas, YAM | 1 |
| Bradbury, J; Gale, J; Muthuramalingam, S | 1 |
| Schulmeister, L | 3 |
| Lipp, HP | 1 |
| Gay, WE; Tyson, AM | 1 |
| Langer, SW | 1 |
| Conde-Estévez, D; Mateu-de Antonio, J; Salar, A; Saumell, S | 1 |
| Bassam, A; Csiffári, M; Csotye, J; Dimák, S; Ocsai, H; Pikó, B; Puskásné Szatmári, K; Szabó, Z | 1 |
| Brüggemann, RJ; Graaf, WT; Lesterhuis, WJ; Vos, FY | 1 |
| Jensen, PB; Langer, SW; Sehested, M; Thougaard, AV | 2 |
| Endicott, MM; Northrup, NC; Saba, CF; Venable, RO | 1 |
| De Grève, J; Fontaine, C; Noens, L; Pierre, P | 1 |
| Doroshow, JH | 1 |
| Drake, D | 1 |
| Eisenberg, S | 1 |
| Schrijvers, DL | 1 |
| Jensen, JN; Langer, SW; Lock-Andersen, J; Mejer, J | 1 |
| Abbas, J; Abou-Mourad, Y; El-Saghir, N; Mufarrij, A; Otrock, Z; Salem, Z; Shamseddine, A | 1 |
| Grothe, W; Jordan, K; Schmoll, HJ | 1 |
| Hasinoff, BB | 2 |
| Azemar, M; Frost, A; Gmehling, D; Mross, K; Unger, C | 1 |
| Brouwer, RE; Uges, JW; Vollaard, AM; Wilms, EB | 1 |
| Buter, J; Dahlstrøm, K; de Wit, M; Eidtmann, H; Giaccone, G; Jensen, PB; Knoblauch, P; Langer, SW; Mouridsen, HT; Rasmussen, A; Rosti, G | 1 |
| Ward, MS | 1 |
| Parsons, JL | 1 |
| Held-Warmkessel, J | 1 |
| Dagher, R; Justice, R; Kane, RC; McGuinn, WD; Pazdur, R | 1 |
| Buter, J; Giaccone, G; Jensen, PB; Langer, SW; Sehested, M | 1 |
| Jensen, PB; Langer, SW; Sehested, M | 2 |
| Bos, AM; van der Graaf, WT; Willemse, PH | 1 |
11 review(s) available for razoxane and Extravasation of Contrast Media
| Article | Year |
|---|---|
Delayed presentation of doxorubicin extravasation into pleural space: Case report and review of literature.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Doxorubicin; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Middle Aged; Razoxane | 2021 |
Dexrazoxane efficacy for anthracycline extravasation: use in UK clinical practice.
Topics: Adult; Aged; Anthracyclines; Antidotes; Antineoplastic Agents; Breast Neoplasms; Chelating Agents; Esophageal Neoplasms; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Male; Middle Aged; Razoxane | 2013 |
[Extra- and paravasation of cytotoxic drugs. Pathomechanisms and current preventive measures].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Drug Interactions; Extravasation of Diagnostic and Therapeutic Materials; Humans; Hyaluronoglucosaminidase; Mitomycin; Organoplatinum Compounds; Razoxane; Taxoids; Vinca Alkaloids | 2010 |
Extravasation of chemotherapy.
Topics: Anthracyclines; Drug-Related Side Effects and Adverse Reactions; Extravasation of Diagnostic and Therapeutic Materials; Humans; Pharmaceutical Preparations; Razoxane; Treatment Outcome | 2010 |
[Extravasation of cytostatic drugs].
Topics: Antidotes; Antineoplastic Agents; Catheters, Indwelling; Cryotherapy; Cytostatic Agents; Dimethyl Sulfoxide; Extravasation of Diagnostic and Therapeutic Materials; Humans; Hungary; Hyaluronoglucosaminidase; Infusions, Intravenous; Interdisciplinary Communication; Irritants; Razoxane; Risk Factors; Skin; Thiosulfates; United States | 2011 |
Dexrazoxane for the prevention of cardiac toxicity and treatment of extravasation injury from the anthracycline antibiotics.
Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Cardiotonic Agents; Extravasation of Diagnostic and Therapeutic Materials; Heart Diseases; Humans; Injections, Intravenous; Iron; Razoxane; Reactive Oxygen Species | 2012 |
BET 3: emergency management of anthracycline extravasation.
Topics: Adult; Antibiotics, Antineoplastic; Chelating Agents; Doxorubicin; Emergency Service, Hospital; Extravasation of Diagnostic and Therapeutic Materials; Hodgkin Disease; Humans; Male; Razoxane | 2012 |
Extravasation: a dreaded complication of chemotherapy.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Dimethyl Sulfoxide; Doxorubicin; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Injections, Intravenous; Mitomycin; Necrosis; Razoxane; Skin Ulcer | 2003 |
Dexrazoxane use in the prevention of anthracycline extravasation injury.
Topics: Anthracyclines; Clinical Trials as Topic; Edetic Acid; Extravasation of Diagnostic and Therapeutic Materials; Molecular Structure; Razoxane | 2006 |
Totect: a new agent for treating anthracycline extravasation.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Antidotes; Biopsy; Chelating Agents; Debridement; Drug Administration Schedule; Extravasation of Diagnostic and Therapeutic Materials; Humans; Necrosis; Nurse's Role; Nursing Assessment; Oncology Nursing; Patient Selection; Practice Guidelines as Topic; Razoxane; Skin Transplantation; Time Factors | 2007 |
The use of dexrazoxane for the prevention of anthracycline extravasation injury.
Topics: Animals; Anthracyclines; Antineoplastic Agents; Cardiotonic Agents; Extravasation of Diagnostic and Therapeutic Materials; Humans; Razoxane | 2008 |
1 trial(s) available for razoxane and Extravasation of Contrast Media
| Article | Year |
|---|---|
Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antibiotics, Antineoplastic; Debridement; DNA Topoisomerases, Type II; Enzyme Inhibitors; Europe; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Necrosis; Prospective Studies; Razoxane; Topoisomerase II Inhibitors; Treatment Outcome | 2007 |
24 other study(ies) available for razoxane and Extravasation of Contrast Media
| Article | Year |
|---|---|
Dexrazoxane treatment for intrathoracic anthracycline extravasation.
Topics: Adult; Anthracyclines; Catheterization, Central Venous; Chelating Agents; Drainage; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Rare Diseases; Razoxane; Treatment Outcome; Vena Cava, Superior; Wounds, Penetrating | 2008 |
Dexrazoxane: new indication. Anthracycline extravasation: continue using dimethyl sulfoxide.
Topics: Anthracyclines; Dimethyl Sulfoxide; Drug Approval; Extravasation of Diagnostic and Therapeutic Materials; France; Humans; Infections; Infusions, Intravenous; Razoxane | 2009 |
Successful experience utilizing dexrazoxane treatment for an anthracycline extravasation.
Topics: Adult; Antibiotics, Antineoplastic; Chelating Agents; Doxorubicin; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Razoxane; Treatment Outcome | 2010 |
Successful dexrazoxane treatment of a potentially severe extravasation of concentrated doxorubicin.
Topics: Adult; Antibiotics, Antineoplastic; Doxorubicin; Extravasation of Diagnostic and Therapeutic Materials; Hodgkin Disease; Humans; Male; Razoxane; Treatment Outcome | 2010 |
Recovery of symptomatic extravasation of liposomal doxorubicin after dexrazoxane treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Doxorubicin; Drug Administration Schedule; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Infusions, Intravenous; Middle Aged; Ovarian Neoplasms; Razoxane | 2012 |
Treatment of experimental extravasation of amrubicin, liposomal doxorubicin, and mitoxantrone with dexrazoxane.
Topics: Animals; Anthracyclines; Antineoplastic Agents; Disease Models, Animal; Doxorubicin; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Mice; Mitoxantrone; Razoxane; Treatment Outcome | 2012 |
Dexrazoxane treatment of doxorubicin extravasation injury in four dogs.
Topics: Animals; Chelating Agents; Dogs; Doxorubicin; Drug Administration Schedule; Extravasation of Diagnostic and Therapeutic Materials; Female; Male; Razoxane; Retrospective Studies; Treatment Outcome | 2012 |
Savene® (dexrazoxane) use in clinical practice.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Belgium; Catheterization, Central Venous; Chelating Agents; Data Collection; Debridement; Extravasation of Diagnostic and Therapeutic Materials; Humans; Neoplasms; Razoxane; Retrospective Studies; Surveys and Questionnaires; Treatment Outcome | 2012 |
The case of the vexing vesicant.
Topics: Angioedema; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Injections, Intravenous; Irritants; Razoxane | 2012 |
Dexrazoxane-a promising antidote in the treatment of accidental extravasation of anthracyclines.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Epirubicin; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Razoxane | 2003 |
Dexrazoxane for anthracycline extravasation and GM-CSF for skin ulceration and wound healing.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chelating Agents; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Doxorubicin; Extravasation of Diagnostic and Therapeutic Materials; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Infusions, Intravenous; Injections, Intralesional; Randomized Controlled Trials as Topic; Razoxane; Skin Ulcer; Thorax; Wound Healing | 2004 |
[Extravasation of chemotherapeutic agents: prevention and therapy].
Topics: Antineoplastic Agents; Catheterization, Central Venous; Diagnosis, Differential; Dimethyl Sulfoxide; Extravasation of Diagnostic and Therapeutic Materials; Humans; Iatrogenic Disease; Peptide Hydrolases; Razoxane; Risk Factors; Thiosulfates; Time Factors | 2005 |
Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone.
Topics: Administration, Topical; Animals; Antibiotics, Antineoplastic; Daunorubicin; Dimethyl Sulfoxide; Drug Therapy, Combination; Extravasation of Diagnostic and Therapeutic Materials; Female; Hydrocortisone; Injections, Intralesional; Injections, Intraperitoneal; Mice; Mice, Inbred Strains; Razoxane | 2006 |
Treatment of anthracycline extravasation with dexrazoxane -- clinical experience.
Topics: Aged; Anthracyclines; Antineoplastic Agents; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Razoxane; Treatment Outcome | 2006 |
Intrapleural extravasation of epirubicin, 5-fluouracil, and cyclophosphamide, treated with dexrazoxane.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Extravasation of Diagnostic and Therapeutic Materials; Female; Fluorouracil; Humans; Mastectomy, Segmental; Middle Aged; Pleural Cavity; Pleural Effusion; Razoxane; Treatment Outcome | 2006 |
Infiltration and extravasation.
Topics: Antidotes; Drug Approval; Extravasation of Diagnostic and Therapeutic Materials; Humans; Irritants; Oncology Nursing; Practice Guidelines as Topic; Razoxane; Societies, Nursing; United States; United States Food and Drug Administration | 2007 |
Re: Totect: a new agent for treating anthracycline extravasation.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Chelating Agents; Drug Approval; Extravasation of Diagnostic and Therapeutic Materials; Humans; Patient Selection; Razoxane; United States; United States Food and Drug Administration | 2007 |
TopoTarget responds.
Topics: Anthracyclines; Antineoplastic Agents; Chelating Agents; Drug Approval; Drug Costs; Extravasation of Diagnostic and Therapeutic Materials; Humans; Razoxane; United States; United States Food and Drug Administration | 2007 |
Accidental anthracycline extravasation.
Topics: Antibiotics, Antineoplastic; Chelating Agents; Doxorubicin; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Infusions, Intravenous; Middle Aged; Razoxane | 2007 |
Dexrazoxane (Totect): FDA review and approval for the treatment of accidental extravasation following intravenous anthracycline chemotherapy.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Drug Approval; Extravasation of Diagnostic and Therapeutic Materials; Humans; Infusions, Intravenous; Razoxane; Risk Factors; United States; United States Food and Drug Administration | 2008 |
Dexrazoxane in anthracycline extravasation.
Topics: Animals; Anthracyclines; Antineoplastic Agents; Cardiovascular Agents; Extravasation of Diagnostic and Therapeutic Materials; Humans; Necrosis; Razoxane | 2000 |
Treatment of anthracycline extravasation with dexrazoxane.
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Inhibitors; Extravasation of Diagnostic and Therapeutic Materials; Female; Idarubicin; Mice; Razoxane; Skin Diseases; Topoisomerase II Inhibitors | 2000 |
Dexrazoxane is a potent and specific inhibitor of anthracycline induced subcutaneous lesions in mice.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Area Under Curve; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extravasation of Diagnostic and Therapeutic Materials; Female; Mice; Razoxane; Topoisomerase II Inhibitors; Ulcer | 2001 |
A new conservative approach to extravasation of anthracyclines with dimethylsulfoxide and dexrazoxane.
Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cryotherapy; Cyclophosphamide; Dimethyl Sulfoxide; Edema; Enzyme Inhibitors; Epirubicin; Erythema; Extravasation of Diagnostic and Therapeutic Materials; Female; Fluorouracil; Free Radical Scavengers; Hand; Humans; Hydrocortisone; Infusions, Intravenous; Iron Chelating Agents; Pain; Pain Management; Razoxane; Ulcer | 2001 |